Market Place
Sourcing Support
PerkinElmer Acquires Covaris to Create an Innovation-Led Platform
04 Dec 2023 //
BUSINESSWIRE
PerkinElmer rebrands slimmed-down medtech business as Revvity
09 May 2023 //
FIERCE BIOTECH
PerkinElmer Board Declares Quarterly Dividend
25 Apr 2023 //
BUSINESSWIRE
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
12 Apr 2023 //
BUSINESSWIRE
PerkinElmer completes $2.45B split into two separate companies
14 Mar 2023 //
FIERCE BIOTECH
PerkinElmer Completes Divestiture of its Enterprise Services Businesses
13 Mar 2023 //
BUSINESSWIRE
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences Investor Forum
09 Mar 2023 //
BUSINESSWIRE
PerkinElmer Launches EnVison Nexus Plate Reader to Drive Improved Research
24 Feb 2023 //
BUSINESSWIRE
PerkinElmer to Present at Upcoming Investor Conferences
22 Feb 2023 //
BUSINESSWIRE
PerkinElmer Announces Financial Results for Fourth Quarter and Full Year of 2022
14 Feb 2023 //
BUSINESSWIRE
PerkinElmer Board Declares Quarterly Dividend
27 Jan 2023 //
BUSINESSWIRE
PerkinElmer Board Declares Quarterly Dividend
26 Jan 2023 //
BUSINESSWIRE
PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023
09 Jan 2023 //
BUSINESSWIRE
PerkinElmer to Present at J.P. Morgan Healthcare Conference
19 Dec 2022 //
BUSINESSWIRE
PerkinElmer Helps Accelerate Gene Therapy Research
21 Nov 2022 //
BUSINESSWIRE
PerkinElmer Announces EONIS SCID-SMA is First to Receive Authorization by FDA
14 Nov 2022 //
BUSINESSWIRE
PerkinElmer to Present at 2022 Stifel Healthcare Conference
10 Nov 2022 //
BUSINESSWIRE
PerkinElmer Announces Financial Results for the Third Quarter of 2022
08 Nov 2022 //
BUSINESSWIRE
PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress
07 Nov 2022 //
BUSINESSWIRE
MDIC Partners with PerkinElmer`s Horizon Discovery
19 Oct 2022 //
BUSINESSWIRE
PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022
17 Oct 2022 //
BUSINESSWIRE
PerkinElmer Donation Helps Expand Capacity for Sickle Cell Disease Screening
13 Oct 2022 //
BUSINESSWIRE
PerkinElmer Unveils Industry-first Cell Analysis Solution to Cell & Gene Therapy
26 Sep 2022 //
BUSINESSWIRE
PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell
22 Sep 2022 //
BUSINESSWIRE
PerkinElmer to Present at Upcoming Investor Conferences
24 Aug 2022 //
BUSINESSWIRE
Moderna, after firing newly hired CFO, finds replacement in PerkinElmer exec
18 Aug 2022 //
BIOPHARMADIVE
PerkinElmer Announces Finance Leadership Transition
17 Aug 2022 //
BUSINESSWIRE
PerkinElmer to sell off 3 units for $2.45B, reclaim Dx focus
02 Aug 2022 //
FIERCEBIOTECH
PerkinElmer Announces Financial Results for the Second Quarter of 2022
01 Aug 2022 //
BUSINESSWIRE
PerkinElmer Transforms into High Margin Life Sciences & Diagnostics Company
01 Aug 2022 //
BUSINESSWIRE
Two PerkinElmer Tests Added to UK’s Updated NICE Diagnostic Guidance
27 Jul 2022 //
BUSINESSWIRE
PerkinElmer Board Declares Quarterly Dividend
22 Jul 2022 //
BUSINESSWIRE
PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022
14 Jul 2022 //
BUSINESSWIRE
PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform
21 Jun 2022 //
BUSINESSWIRE
PerkinElmer and Novartis Collaborate to Address the Unmet Need of SCD
16 Jun 2022 //
BUSINESSWIRE
PerkinElmer Expands FST Portfolio with AOAC Certified Microbial Count Plates
07 Jun 2022 //
BUSINESSWIRE
PerkinElmer Launches BioQule NGS System to Automate Library Preparation
06 Jun 2022 //
BUSINESSWIRE
PerkinElmer Expands Genomic Testing Services with Ultrarapid Genome Sequencing
16 May 2022 //
BUSINESSWIRE
PerkinElmer Announces Financial Results for the First Quarter of 2022
03 May 2022 //
BUSINESSWIRE
PerkinElmer Board Declares Quarterly Dividend
28 Apr 2022 //
BUSINESSWIRE
PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022
12 Apr 2022 //
BUSINESSWIRE
PerkinElmer Expands In Vivo Portfolio with Vega Widefield PC Ultrasound Imaging
07 Apr 2022 //
BUSINESSWIRE
PerkinElmer Introduces First Ready-to-use HTRF, AlphaLISA Assay Kits
04 Apr 2022 //
BUSINESSWIRE
Innovations in APAC have become cornerstone of future development of IVD
15 Mar 2022 //
BIOSPECTRUMASIA
PerkinElmer Launches Innovative FT-IR Platform
09 Mar 2022 //
BUSINESSWIRE
PerkinElmer Launches ChemDraw V21 Software
02 Mar 2022 //
BUSINESSWIRE
PerkinElmer to Present at Upcoming Investor Conferences
01 Mar 2022 //
BUSINESSWIRE
SIRION Biotech Teams with CRG to Develop New Generation AAV Vectors
16 Feb 2022 //
BUSINESSWIRE
PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
10 Feb 2022 //
BUSINESSWIRE
U.S. CDC Guidance Includes EUROIMMUN Assay in Testing Algorithm for Dengue Virus
03 Feb 2022 //
BUSINESSWIRE
PerkinElmer Announces Financial Results for Q4 and Full Year of 2021
01 Feb 2022 //
BUSINESSWIRE
PerkinElmer Board Declares Quarterly Dividend
27 Jan 2022 //
BUSINESSWIRE
Carterra, PerkinElmer Sign Distribution Agreement For Asia-Pacific & Oceania
14 Dec 2021 //
BUSINESSWIRE
PerkinElmer Confirms That Omicron Variant Does Not Impact SARS-CoV-2
30 Nov 2021 //
BUSINESSWIRE
PerkinElmer & Honeycomb Biotechnologies Launch HIVE scRNAseq Solution
18 Oct 2021 //
BUSINESSWIRE
PerkinElmer’s Horizon Discovery CHOSOURCE Platform To Include CHO-K1 ADCC+
06 Oct 2021 //
BUSINESSWIRE
EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA EUA
05 Oct 2021 //
BUSINESSWIRE
PerkinElmer Completes Acquisition of BioLegend
17 Sep 2021 //
BIOSPACE
PerkinElmer Prices Offering of Senior Notes
08 Sep 2021 //
BUSINESSWIRE
PerkinElmer to Present at 2021 Baird Global Healthcare Conference
24 Aug 2021 //
BUSINESSWIRE
